BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report
Authors:
- Moeko Murano MorikawaMMMoeko Murano Morikawa
- Masanori HaradaMHMasanori Harada
- Ei KishimotoEKEi Kishimoto
- Kosuke SuzukiKSKosuke Suzuki
- Emiko NakagawaENEmiko Nakagawa
- Toshiya HiramatsuTHToshiya Hiramatsu
- Shogo NakaiSNShogo Nakai
- Yurina MurakamiYMYurina Murakami
- Koji NishimotoKNKoji Nishimoto
- Sayomi MatsushimaSMSayomi Matsushima
- Tomohiro UtoTUTomohiro Uto
- Shiro ImokawaSIShiro Imokawa
Open Access
- 30 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (39) , e30806
Abstract
Rationale: The relationship between rheumatoid arthritis (RA) and eosinophilic inflammation is unclear. According to recent studies, it has been suggested that T helper 2 cell responses play a role in the inhibition of RA. It is unclear how the immunological response after coronavirus disease-2019 (COVID-19) vaccination affects T cell immune reactions. Patient concerns and diagnoses: Here, we report the case of an 88-year-old woman diagnosed with RA and chronic eosinophilic pneumonia (CEP). She was diagnosed with CEP about 20 years ago, and, through steroid treatment, she improved and had no relapse for 16 years. At the time of diagnosis of CEP, the rheumatoid factor (RF) was increased; however, there were no joint symptoms. After receiving the COVID-19 vaccine, joint and respiratory symptoms gradually worsened. Laboratory examinations showed increased RF, anti-cyclin citrullinated peptide antibody, and peripheral absolute eosinophil count. Musculoskeletal ultrasonography showed synovitis. Intervention and outcome: Methylprednisolone pulse therapy improved respiratory and joint symptoms immediately; RA and CEP stabilized with no relapses. Lessons: Eosinophilic and rheumatoid reactions following COVID-19 vaccination were an-reported adverse events. Eosinophilic inflammation might be reflected on an anti-inflammatory reaction in initial phase of RA.Keywords
This publication has 15 references indexed in Scilit:
- COVID-19 revisiting inflammatory pathways of arthritisNature Reviews Rheumatology, 2020
- Hypereosinophilic syndrome—a rare adverse event of anti-cytokine treatment in rheumatoid arthritis resolved after Janus kinase inhibitor therapyClinical Rheumatology, 2020
- The trinity of COVID-19: immunity, inflammation and interventionNature Reviews Immunology, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritisNature Reviews Rheumatology, 2018
- Group 2 Innate Lymphoid Cells Attenuate Inflammatory Arthritis and Protect from Bone Destruction in MiceCell Reports, 2018
- ACR/EULAR 2010 rheumatoid arthritis classification criteriaRheumatology, 2012
- Evidence for osteocyte regulation of bone homeostasis through RANKL expressionNature Medicine, 2011
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007
- Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophilsEuropean Journal of Immunology, 1997